MOLN logo

Molecular Partners AG (MOLN) Company Overview

Profile

Full Name:

Molecular Partners AG

Sector:

Healthcare

Industry:

Biotechnology

Country:

Switzerland

IPO:

June 16, 2021

Indexes:

Not included

Website:

http://www.molecularpartners.com

Description:

Molecular Partners AG is a biotechnology company that focuses on developing innovative therapies using a unique technology called DARPins. These small proteins can target specific diseases, especially cancer and viral infections. The company aims to create effective treatments with fewer side effects for patients worldwide.

Key Details

Price

$4.65

Market Cap

$171.41 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$7.84 M(-96.06% YoY)

Annual EPS

-$2.10(-156.71% YoY)

PE Ratio

-

Annual ROE

-29.77%

Annual Debt To Equity

0.00

Beta

1.77

Events Calendar

Earnings

Next earnings date:

Mar 7, 2025

Recent quarterly earnings:

Aug 26, 2024

Recent annual earnings:

Mar 15, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Dec 5, 23 JP Morgan
Neutral
Aug 29, 22 SVB Leerink
Market Perform
May 25, 22 Credit Suisse
Neutral
Apr 27, 22 SVB Leerink
Outperform
Jan 14, 22 SVB Leerink
Outperform
Aug 27, 21 SVB Leerink
Outperform
Jul 13, 21 Cowen & Co.
Outperform

Screeners with MOLN included

Growing Shares Outstanding
Stocks with high beta
Stocks below SMA 200
Healthcare sector
All stocks
Earnings this week
Biotechnology industry
Small cap stocks
NASDAQ earnings calendar

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$4.65
MOLN price is $4.65

Price All-time High

$31.89
MOLN price is currently -85.42% below its historical high of $31.89

Price Analysts Target

-
MOLN price consensus analysts' forecast is unknown

Price Most Recent Change

+1.75%
MOLN price was up +1.75% on Feb 28, 2025

Price YTD Change

-2.06%
MOLN price is down -2.06% since January 1st

Price 3-Year Change

-81.1%
MOLN price is down -81.1% over the past 3 years

Market cap

Market Cap

$171.41 M
MOLN market capitalization is $171.41 million

Market Cap 3-Year Change

-78.42%
MOLN market capitalization is down -78.42% over the past 3 years

Market Cap All-time High

$1.03 B
MOLN market capitalization is currently -83.35% below its historical high of $1.03 billion

Market Cap Sector Rank

53.62%
MOLN market capitalization is higher than 53.62% of companies in Healthcare sector

Technical

Beta

1.77
MOLN beta is 1.77

200-day SMA

$5.57
MOLN price is currently -16.50% below its 200-day simple moving average

14-day RSI

50.74
MOLN 14-day relative strength index is 50.74

30-day Relative Volume

1.33
MOLN 30-day relative volume is 1.33

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$7.84 M
MOLN annual revenue is $7.84 million

Annual Revenue Analysts Estimate

$3.33 M
MOLN annual revenue is currently +135.14% higher than the consensus analysts' forecast

Annual Revenue 1-Year Change

-96.06%
MOLN annual revenue is down -96.06% year-on-year

Annual Revenue Sector Rank

27.69%
MOLN annual revenue is higher than 27.69% of companies in Healthcare sector

Profit

Annual Gross Profit

-
MOLN annual gross profit value is unknown

Annual Gross Margin

-
MOLN annual gross profit margin value is unknown

Annual Operating Profit

-$68.05 M
MOLN annual operating income is -$68.05 million

Annual Operating Margin

-868.26%
MOLN annual operating profit margin is -868.26%

Annual Net Income

-$69.03 M
MOLN annual net profit is -$69.03 million

Annual Net Margin

-880.70%
MOLN annual net profit margin is -880.70%

EPS

Annual EPS

-$2.10
MOLN annual earnings per share is -$2.10

Annual EPS Analysts Estimate

-$1.60
MOLN annual earnings per share is currently +31.14% higher than the consensus analysts' forecast

Annual EPS 1-Year Change

-156.71%
MOLN annual earnings per share is down -156.71% year-on-year

Annual EPS Sector Rank

40.69%
MOLN annual earnings per share is higher than 40.69% of companies in Healthcare sector

ROA & ROE

Annual ROA

-26.60%
MOLN annual return on assets is -26.60%

Annual ROE

-29.77%
MOLN annual return on equity is -29.77%

EBIT & EBITDA

Annual EBIT

-$68.99 M
MOLN annual earnings before interest & taxes is -$68.99 million

Annual EBITDA

-$66.30 M
MOLN annual EBITDA is -$66.30 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
MOLN price to earnings ratio value is unknown

PE Ratio Sector Rank

-
MOLN price to earnings ratio is unknown

PB Ratio

PB Ratio

1.04
MOLN price to book ratio is 1.04

PB Ratio Sector Rank

44.11%
MOLN price to book ratio is higher than 44.11% of companies in Healthcare sector

PS Ratio

PS Ratio

25.21
MOLN price to sales ratio is 25.21

PS Ratio Sector Rank

87.5%
MOLN price to sales ratio is higher than 87.5% of companies in Healthcare sector

Enterprise value

Enterprise Value

$96.52 M
MOLN enterprise value is $96.52 million

Enterprise Value Sector Rank

47.96%
MOLN enterprise value is higher than 47.96% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-1.42
MOLN EV/EBITDA is -1.42

EV/EBITDA Sector Rank

40.49%
MOLN EV/EBITDA is higher than 40.49% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

13.35
MOLN annual current ratio is 13.35

Annual Quick Ratio

-
MOLN annual quick ratio value is unknown

Leverage

Annual Debt To Equity

0.00
MOLN annual debt to equity ratio is 0.00

Annual Interest Coverage Ratio

-1820.35
MOLN annual interest coverage ratio is -1820.35

Risk & Stability

Piotroski F-Score

-
MOLN piotroski f-score value is unknown

Altman Z-Score

2.73
MOLN altman z-score is 2.73

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$236.15 M
MOLN annual total assets is $236.15 million

Annual Non Current Assets

$7.02 M
MOLN annual long term assets is $7.02 million

Annual Current Assets

$229.13 M
MOLN annual total current assets is $229.13 million

Annual Cash & Cash Equivalents

$80.14 M
MOLN annual cash & cash equivalents is $80.14 million

Equity

Annual Book Value

$210.05 M
MOLN annual book value is $210.05 million

Annual Working Capital

$211.97 M
MOLN annual working capital is $211.97 million

Liabilities

Annual Total Liabilities

$26.10 M
MOLN annual total liabilities is $26.10 million

Annual Total Long Term Liabilities

$8.94 M
MOLN annual total long term liabilities is $8.94 million

Annual Current Liabilities

$17.16 M
MOLN annual total current liabilities is $17.16 million

Annual Accounts Payable

$488.10 K
MOLN annual accounts payable is $488.10 thousand

Debt

Annual Total Debt

$4.35 M
MOLN annual total debt is $4.35 million

Annual Total Debt 1-Year Change

-16.88%
MOLN annual total debt is down -16.88% year-on-year

Annual Long Term Debt

$2.91 M
MOLN annual long term debt is $2.91 million

Annual Short Term Debt

$1.44 M
MOLN annual short term debt is $1.44 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$75.89 M
MOLN annual total expenses is $75.89 million

Annual Operating Expenses

$75.89 M
MOLN annual total operating expenses is $75.89 million

Annual Cost Of Goods Sold

-
MOLN annual cost of goods sold value is unknown

Annual SGA

$21.15 M
MOLN annual SGA is $21.15 million

Annual D&A

$2.70 M
MOLN annual depreciation & amortization is $2.70 million

Annual Interest Expense

$37.90 K
MOLN annual interest expense is $37.90 thousand

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$65.71 M
MOLN annual cash flow from operations is -$65.71 million

Annual CFO 1-Year Change

-152.86%
MOLN annual cash flow from operations is down -152.86% year-on-year

Annual CFI

$49.71 M
MOLN annual cash flow from investing activities is $49.71 million

Annual CFI 1-Year Change

+146.88%
MOLN annual cash flow from investing activities is up +146.88% year-on-year

Annual CFF

-$1.30 M
MOLN annual cash flow from financing activities is -$1.30 million

Annual CFF 1-Year Change

+21.05%
MOLN annual cash flow from financing activities is up +21.05% year-on-year

Free CashFlow

Annual FCF

-$66.61 M
MOLN annual free cash flow is -$66.61 million

Annual FCF 1-Year Change

-154.23%
MOLN annual free cash flow is down -154.23% year-on-year

CAPEX

Annual CAPEX

$899.80 K
MOLN annual capital expenditures is $899.80 thousand

Annual CAPEX 1-Year Change

-39.44%
MOLN annual capital expenditures is down -39.44% year-on-year

Institutional Ownership

Similar stocks

PLX logo
Protalix BioTherapeutics (PLX)
PBYI logo
Puma Biotechnology (PBYI)
IPHA logo
Innate Pharma SA (IPHA)
CYBN logo
Cybin (CYBN)
ADCT logo
ADC Therapeutics SA (ADCT)
JYNT logo
Joint (JYNT)
INFU logo
InfuSystem Holdings (INFU)
CARGO Therapeutics (CRGX)
STXS logo
Stereotaxis (STXS)

FAQ

  • What is the ticker symbol for Molecular Partners AG?
  • Does Molecular Partners AG pay dividends?
  • What sector is Molecular Partners AG in?
  • What industry is Molecular Partners AG in?
  • What country is Molecular Partners AG based in?
  • When did Molecular Partners AG go public?
  • Is Molecular Partners AG in the S&P 500?
  • Is Molecular Partners AG in the NASDAQ 100?
  • Is Molecular Partners AG in the Dow Jones?
  • When was Molecular Partners AG's last earnings report?
  • When does Molecular Partners AG report earnings?

What is the ticker symbol for Molecular Partners AG?

The ticker symbol for Molecular Partners AG is NASDAQ:MOLN

Does Molecular Partners AG pay dividends?

No, Molecular Partners AG does not pay dividends

What sector is Molecular Partners AG in?

Molecular Partners AG is in the Healthcare sector

What industry is Molecular Partners AG in?

Molecular Partners AG is in the Biotechnology industry

What country is Molecular Partners AG based in?

Molecular Partners AG is headquartered in Switzerland

When did Molecular Partners AG go public?

Molecular Partners AG's initial public offering (IPO) was on June 16, 2021

Is Molecular Partners AG in the S&P 500?

No, Molecular Partners AG is not included in the S&P 500 index

Is Molecular Partners AG in the NASDAQ 100?

No, Molecular Partners AG is not included in the NASDAQ 100 index

Is Molecular Partners AG in the Dow Jones?

No, Molecular Partners AG is not included in the Dow Jones index

When was Molecular Partners AG's last earnings report?

Molecular Partners AG's most recent earnings report was on Aug 26, 2024

When does Molecular Partners AG report earnings?

The next expected earnings date for Molecular Partners AG is Mar 7, 2025